Article
Dualmarker: a flexible toolset for exploratory analysis of combinatorial dual biomarkers for clinical efficacy.
BMC bioinformatics - 17 Mar 2021
Ma Xiaopeng, Huang Ruiqi, Wu Xikun, Zhang Pei
Abstract excerpt
BACKGROUND: An increasing number of clinical trials require biomarker-driven patient stratification, especially for revolutionary immune checkpoint blockade therapy. Due to the complicated interaction between a tumor and its microenvironment, single biomarkers, such as PDL1 protein level, tumor mutational burden (TMB), single gene mutation and expression, are far from satisfactory for response prediction or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
